Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 10791395)

1.

The taxanes: an update.

Crown J, O'Leary M.

Lancet. 2000 Apr 1;355(9210):1176-8. Review.

PMID:
10791395
2.

Expanding horizons: an update on the use of docetaxel in non-small cell lung, ovarian, and breast cancers.

Hortobagyi GN, Kris MG.

Semin Oncol. 2002 Jun;29(3 Suppl 12):1-3. Review. No abstract available.

PMID:
12170444
3.

Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.

Sparano JA.

Clin Breast Cancer. 2000 Apr;1(1):32-40; discussion 41-2. Review.

PMID:
11899388
4.

Risks and benefits of taxanes in breast and ovarian cancer.

Michaud LB, Valero V, Hortobagyi G.

Drug Saf. 2000 Nov;23(5):401-28. Review.

PMID:
11085347
5.
6.

The development of docetaxel (Taxotere) in non-small cell lung cancer.

Kris MG, Miller VA, Ng KK, Grant SC.

Semin Oncol. 1997 Aug;24(4 Suppl 14):S14-1-S14-4. No abstract available.

PMID:
9335515
7.

Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.

Chu Q, Vincent M, Logan D, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

Lung Cancer. 2005 Dec;50(3):355-74. Epub 2005 Aug 31. Review.

PMID:
16139391
8.

[Docetaxel].

Takigawa N.

Nihon Rinsho. 2002 May;60 Suppl 5:349-52. Review. Japanese. No abstract available.

PMID:
12101686
9.

Docetaxel (Taxotere) in the treatment of non-small cell lung cancer.

Kris MG, Millward M.

Semin Oncol. 1999 Jun;26(3 Suppl 10):1-2. No abstract available.

PMID:
10437742
10.

[Second-line and beyond: Docetaxel in the treatment of non-small-cell lung cancer].

Rinaldi M.

Tumori. 2001 Nov-Dec;87(6):A6-9. Review. Italian. No abstract available.

PMID:
11995708
11.

Docetaxel: a review of its pharmacology and clinical activity.

Trudeau ME.

Can J Oncol. 1996 Jun;6(1):443-57. Review.

PMID:
8853517
12.

Docetaxel as second-line chemotherapy for non-small-cell lung cancer.

Roila F, Del Favero A, Ballatori E.

J Clin Oncol. 2000 Nov 1;18(21):3738-9. No abstract available.

PMID:
11054450
13.

The taxoids: paclitaxel and docetaxel.

Gelmon K.

Lancet. 1994 Nov 5;344(8932):1267-72. Review. No abstract available.

PMID:
7967989
14.

Taxing the taxanes: overused or undersold?

Miller M.

J Natl Cancer Inst. 1999 Dec 15;91(24):2077-8. No abstract available.

15.

Advanced non-small cell lung carcinoma: the emerging role of docetaxel.

Langer CJ.

Invest New Drugs. 2000 Feb;18(1):17-28. Review.

PMID:
10830138
16.

Docetaxel in the treatment of breast cancer: an update on recent studies.

Nabholtz JM, Reese DM, Lindsay MA, Riva A.

Semin Oncol. 2002 Jun;29(3 Suppl 12):28-34. Review.

PMID:
12170449
17.

[Docetaxel (taxotere): current status of clinical development in non-small-cell bronchial carcinoma (NSCLC)].

Manegold C.

Med Klin (Munich). 1998 Sep 15;93 Suppl 3:16-21. Review. German.

PMID:
9796220
18.

Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: an international update.

Kris MG, Manegold C.

Semin Oncol. 2001 Feb;28(1 Suppl 2):1-3.

PMID:
11284618
19.

[Docetaxel (taxotere) in non-small-cell bronchial carcinoma].

Manegold C.

Med Klin (Munich). 1997 Sep 15;92 Suppl 4:10-5. Review. German.

PMID:
9446014
20.

[Taxanes in the treatment of breast and ovarian cancers: current indications and results].

EspiƩ M, Cuvier C, Gorins A, Marty M.

Contracept Fertil Sex. 1998 Nov;26(11):805-11. Review. French.

PMID:
9864888
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk